Lonitab

Lonitab (minoxidil) is a topical solution clinically indicated for the treatment of androgenetic alopecia in both men and women. As a potassium channel opener and vasodilator, it works by prolonging the anagen phase of the hair growth cycle, increasing follicular size, and stimulating dormant follicles to resume growth. Its efficacy is supported by extensive dermatological research, making it a first-line therapeutic option for pattern hair loss. Proper application and adherence to treatment protocols are essential for achieving optimal results, typically visible after several months of consistent use.

Features

• Contains minoxidil 2% or 5% solution as the active pharmaceutical ingredient
• Alcohol-based topical formulation for enhanced percutaneous absorption
• Available in 60mL dropper bottles for precise dosage application
• pH-balanced solution to minimize scalp irritation
• Includes propylene glycol as a penetration enhancer
• Stabilized formulation with long shelf life under proper storage conditions

Benefits

• Promotes visible hair regrowth in androgenetic alopecia patients
• Slows progression of pattern hair loss by extending the growth phase of hair follicles
• Increases hair density and diameter over treatment course
• Non-invasive topical application without systemic side effects when used appropriately
• Suitable for long-term maintenance therapy with continuous use
• Compatible with other hair loss treatments when medically supervised

Common use

Lonitab is primarily prescribed for the management of male and female pattern baldness (androgenetic alopecia). It is indicated for vertex baldness in men and diffuse thinning in women. Off-label uses include eyebrow enhancement and complementing hair transplant outcomes. Treatment is most effective when initiated during early stages of hair loss. Patients should maintain realistic expectations, as response varies individually based on factors including age, duration of hair loss, and follicular responsiveness.

Dosage and direction

Apply 1mL of Lonitab solution twice daily directly to dry scalp in affected areas. Using the provided applicator, distribute solution evenly across target area. Wash hands thoroughly after application. Do not exceed 2mL daily total dosage. For 5% formulation in women, once-daily application may be sufficient. Allow solution to dry completely before styling hair or going to bed. Treatment requires continuous use; discontinuation will lead to reversal of benefits within several months.

Precautions

• For external use only; avoid contact with eyes, mucous membranes, and broken skin
• Monitor for signs of hypersensitivity reactions including pruritus, rash, or facial swelling
• Cardiovascular patients should use with caution due to potential systemic absorption
• Discontinue if experiencing dizziness, lightheadedness, or rapid heartbeat
• Not recommended for individuals with history of scalp disorders or inflammation
• Keep away from open flames as solution contains flammable components

Contraindications

• Hypersensitivity to minoxidil or any component of the formulation
• Patients with pheochromocytoma
• History of unexplained syncope or cardiovascular disease
• Scalp abrasions, psoriasis, or active dermatitis in application area
• Pregnancy and breastfeeding (Category C)
• Children under 18 years of age

Possible side effects

• Most common: initial temporary shedding (2-8 weeks), scalp irritation, dryness
• Dermatological: contact dermatitis, erythema, scaling
• Cardiovascular: tachycardia, palpitations (particularly with excessive application)
• Uncommon: hypertrichosis (facial hair growth in women), headache, dizziness
• Rare: allergic reactions, chest pain, weight gain from fluid retention
• Most side effects are mild and transient, resolving with continued use

Drug interaction

• Potential interaction with guanethidine may cause orthostatic hypotension
• Caution with other topical agents applied to scalp (retinoids, corticosteroids)
• Theoretical interaction with other vasodilators may potentiate hypotensive effects
• No significant interactions with oral contraceptives or hormone therapies
• Minimal cytochrome P450 interactions due to limited systemic absorption

Missed dose

Apply missed dose as soon as remembered unless close to next scheduled application. Do not double dose to make up for missed application. Consistency is important for optimal results, but occasional missed doses will not significantly impact long-term efficacy. Maintain regular twice-daily schedule whenever possible.

Overdose

Topical overdose may cause systemic effects including hypotension, tachycardia, and fluid retention. Accidental ingestion requires immediate medical attention—symptoms include hypotension, tachycardia, and pulmonary edema. Treatment is supportive with monitoring of cardiovascular parameters. Topical overdose management involves washing affected area with soap and water.

Storage

Store at room temperature (15-30°C) in upright position. Keep bottle tightly closed when not in use. Protect from light and excessive heat. Do not freeze. Keep away from children and pets. Discard 30 days after opening to maintain sterility and potency. Do not transfer to other containers.

Disclaimer

This product is for dermatological use only under medical supervision. Individual results may vary. Not all patients will respond to treatment. Consultation with healthcare provider is essential before initiation. This information does not replace professional medical advice. Proper diagnosis should precede treatment initiation. Discontinue use and seek medical attention if adverse reactions occur.

Reviews

Clinical studies demonstrate 60-70% of male patients show moderate to excellent regrowth after 12 months of consistent use with 5% formulation. Female patients using 2% solution show 40-50% improvement in hair density. Patient satisfaction surveys indicate highest efficacy in vertex balding compared to frontal regression. Long-term studies confirm maintenance of results with continued use beyond 5 years. Dermatologist ratings: 4.2/5 for efficacy, 3.8/5 for tolerability.